1. Home
  2. BOXL vs REVB Comparison

BOXL vs REVB Comparison

Compare BOXL & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOXL
  • REVB
  • Stock Information
  • Founded
  • BOXL 1985
  • REVB 2020
  • Country
  • BOXL United States
  • REVB United States
  • Employees
  • BOXL N/A
  • REVB N/A
  • Industry
  • BOXL Telecommunications Equipment
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOXL Telecommunications
  • REVB Health Care
  • Exchange
  • BOXL Nasdaq
  • REVB Nasdaq
  • Market Cap
  • BOXL 4.9M
  • REVB 4.4M
  • IPO Year
  • BOXL 2017
  • REVB N/A
  • Fundamental
  • Price
  • BOXL $1.52
  • REVB $1.58
  • Analyst Decision
  • BOXL Buy
  • REVB
  • Analyst Count
  • BOXL 3
  • REVB 0
  • Target Price
  • BOXL $5.00
  • REVB N/A
  • AVG Volume (30 Days)
  • BOXL 2.3M
  • REVB 890.8K
  • Earning Date
  • BOXL 11-12-2025
  • REVB 11-07-2025
  • Dividend Yield
  • BOXL N/A
  • REVB N/A
  • EPS Growth
  • BOXL N/A
  • REVB N/A
  • EPS
  • BOXL N/A
  • REVB N/A
  • Revenue
  • BOXL $113,560,000.00
  • REVB N/A
  • Revenue This Year
  • BOXL N/A
  • REVB N/A
  • Revenue Next Year
  • BOXL N/A
  • REVB N/A
  • P/E Ratio
  • BOXL N/A
  • REVB N/A
  • Revenue Growth
  • BOXL N/A
  • REVB N/A
  • 52 Week Low
  • BOXL $1.06
  • REVB $1.50
  • 52 Week High
  • BOXL $10.65
  • REVB $60.48
  • Technical
  • Relative Strength Index (RSI)
  • BOXL 42.73
  • REVB 26.42
  • Support Level
  • BOXL $1.63
  • REVB $1.50
  • Resistance Level
  • BOXL $3.25
  • REVB $2.90
  • Average True Range (ATR)
  • BOXL 0.22
  • REVB 0.20
  • MACD
  • BOXL 0.01
  • REVB -0.12
  • Stochastic Oscillator
  • BOXL 7.03
  • REVB 4.29

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: